Back to Search
Start Over
A Rare Report of the Coexistence of Sickle Cell Disease, Neurofibromatosis Type 1, and Intracranial Hypertension in a Pediatric Patient.
- Source :
-
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 Apr 01; Vol. 45 (3), pp. 155-158. Date of Electronic Publication: 2023 Mar 03. - Publication Year :
- 2023
-
Abstract
- A pediatric female with sickle cell disease (SCD) and neurofibromatosis type 1 was noted to have incidental papilledema, with subsequent workup showing an elevated opening pressure. She was diagnosed with intracranial hypertension and began treatment with acetazolamide. Hydroxyurea was also discontinued. Acetazolamide was tapered off, and hydroxyurea was restarted with no worsening in her ophthalmologic exam. We report this case due to the rare occurrence of all 3 conditions, and while intracranial hypertension has been reported in SCD, the diagnostic workup for papilledema in hemoglobinopathies is not well defined. This case helps delineate the presentation and diagnostic workup of papilledema in SCD.<br />Competing Interests: The authors declare no conflict of interest.<br /> (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Subjects :
- Humans
Child
Female
Acetazolamide therapeutic use
Hydroxyurea therapeutic use
Papilledema complications
Intracranial Hypertension complications
Intracranial Hypertension diagnosis
Intracranial Hypertension drug therapy
Anemia, Sickle Cell complications
Neurofibromatosis 1 complications
Neurofibromatosis 1 diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1536-3678
- Volume :
- 45
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of pediatric hematology/oncology
- Publication Type :
- Academic Journal
- Accession number :
- 36898033
- Full Text :
- https://doi.org/10.1097/MPH.0000000000002647